[DPHARMA] QoQ Annualized Quarter Result on 31-Dec-2013 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Feb-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Dec-2013 [#4]
Profit Trend
QoQ- 0.13%
YoY- 24.07%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 167,916 162,236 161,980 162,405 155,561 151,652 151,348 7.16%
PBT 43,452 42,604 44,700 40,175 41,356 43,926 35,824 13.72%
Tax -10,685 -10,820 -11,240 -7,900 -9,122 -9,150 -9,028 11.87%
NP 32,766 31,784 33,460 32,275 32,233 34,776 26,796 14.33%
-
NP to SH 32,766 31,784 33,460 32,275 32,233 34,776 26,796 14.33%
-
Tax Rate 24.59% 25.40% 25.15% 19.66% 22.06% 20.83% 25.20% -
Total Cost 135,149 130,452 128,520 130,130 123,328 116,876 124,552 5.58%
-
Net Worth 187,436 179,045 190,050 181,850 179,125 187,340 176,143 4.22%
Dividend
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Div 7,404 11,103 - 24,293 - 11,101 - -
Div Payout % 22.60% 34.93% - 75.27% - 31.92% - -
Equity
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Net Worth 187,436 179,045 190,050 181,850 179,125 187,340 176,143 4.22%
NOSH 138,841 138,794 138,723 138,817 138,856 138,770 138,695 0.07%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin 19.51% 19.59% 20.66% 19.87% 20.72% 22.93% 17.70% -
ROE 17.48% 17.75% 17.61% 17.75% 17.99% 18.56% 15.21% -
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
RPS 120.94 116.89 116.77 116.99 112.03 109.28 109.12 7.09%
EPS 23.60 22.90 24.12 23.25 23.21 25.06 19.32 14.25%
DPS 5.33 8.00 0.00 17.50 0.00 8.00 0.00 -
NAPS 1.35 1.29 1.37 1.31 1.29 1.35 1.27 4.15%
Adjusted Per Share Value based on latest NOSH - 138,792
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
RPS 17.44 16.85 16.83 16.87 16.16 15.75 15.72 7.16%
EPS 3.40 3.30 3.48 3.35 3.35 3.61 2.78 14.35%
DPS 0.77 1.15 0.00 2.52 0.00 1.15 0.00 -
NAPS 0.1947 0.186 0.1974 0.1889 0.1861 0.1946 0.183 4.21%
Price Multiplier on Financial Quarter End Date
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Date 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 -
Price 3.17 2.97 3.03 2.58 2.55 2.38 2.23 -
P/RPS 2.62 2.54 2.59 2.21 2.28 2.18 2.04 18.13%
P/EPS 13.43 12.97 12.56 11.10 10.99 9.50 11.54 10.63%
EY 7.44 7.71 7.96 9.01 9.10 10.53 8.66 -9.61%
DY 1.68 2.69 0.00 6.78 0.00 3.36 0.00 -
P/NAPS 2.35 2.30 2.21 1.97 1.98 1.76 1.76 21.23%
Price Multiplier on Announcement Date
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Date 21/11/14 26/08/14 20/05/14 26/02/14 19/11/13 28/08/13 27/05/13 -
Price 3.01 3.37 3.09 2.60 2.56 2.44 2.51 -
P/RPS 2.49 2.88 2.65 2.22 2.29 2.23 2.30 5.42%
P/EPS 12.75 14.72 12.81 11.18 11.03 9.74 12.99 -1.23%
EY 7.84 6.80 7.81 8.94 9.07 10.27 7.70 1.20%
DY 1.77 2.37 0.00 6.73 0.00 3.28 0.00 -
P/NAPS 2.23 2.61 2.26 1.98 1.98 1.81 1.98 8.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment